nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.025	0.123	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—DKK1—osteoporosis	0.0135	0.066	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.00943	0.0463	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.00527	0.0259	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—IGF1—osteoporosis	0.00519	0.0255	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—osteoporosis	0.00502	0.0246	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CALCR—osteoporosis	0.00495	0.0243	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—PTH1R—osteoporosis	0.00495	0.0243	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CNR2—osteoporosis	0.00419	0.0206	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00389	0.0191	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—PSMA5—osteoporosis	0.0036	0.0177	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—PSMA2—osteoporosis	0.0036	0.0177	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00333	0.0163	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—TGFB1—osteoporosis	0.00311	0.0153	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—osteoporosis	0.00294	0.0144	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PTH1R—osteoporosis	0.0028	0.0137	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CALCR—osteoporosis	0.0028	0.0137	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—PTH—osteoporosis	0.0026	0.0128	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PTH1R—osteoporosis	0.00254	0.0125	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CALCR—osteoporosis	0.00254	0.0125	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CNR2—osteoporosis	0.00254	0.0124	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—WNT1—osteoporosis	0.00238	0.0117	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SOST—osteoporosis	0.00237	0.0116	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PKM—osteoporosis	0.00237	0.0116	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ANTXR2—osteoporosis	0.00225	0.011	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PGLS—osteoporosis	0.00225	0.011	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—ADCY5—osteoporosis	0.00223	0.0109	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—MGLL—osteoporosis	0.00222	0.0109	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—PTHLH—osteoporosis	0.00216	0.0106	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MGLL—osteoporosis	0.00202	0.00991	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—POMC—osteoporosis	0.00194	0.00954	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GSN—osteoporosis	0.00191	0.00938	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CALCA—osteoporosis	0.0019	0.00932	CbGpPWpGaD
Plerixafor—CXCR4—Disease—LRP5—osteoporosis	0.00166	0.00816	CbGpPWpGaD
Plerixafor—Constipation—Calcitriol—osteoporosis	0.00166	0.00209	CcSEcCtD
Plerixafor—Pain—Calcitriol—osteoporosis	0.00166	0.00209	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SOST—osteoporosis	0.00166	0.00815	CbGpPWpGaD
Plerixafor—Flatulence—Conjugated Estrogens—osteoporosis	0.00165	0.00207	CcSEcCtD
Plerixafor—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00165	0.00207	CcSEcCtD
Plerixafor—Urticaria—Estropipate—osteoporosis	0.00164	0.00207	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—POMC—osteoporosis	0.00164	0.00805	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Raloxifene—osteoporosis	0.00164	0.00206	CcSEcCtD
Plerixafor—Diarrhoea—Etidronic acid—osteoporosis	0.00164	0.00206	CcSEcCtD
Plerixafor—Abdominal pain—Estropipate—osteoporosis	0.00164	0.00205	CcSEcCtD
Plerixafor—Feeling abnormal—Ibandronate—osteoporosis	0.00164	0.00205	CcSEcCtD
Plerixafor—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00163	0.00205	CcSEcCtD
Plerixafor—Gastrointestinal pain—Ibandronate—osteoporosis	0.00162	0.00204	CcSEcCtD
Plerixafor—Arthralgia—Pamidronate—osteoporosis	0.00162	0.00204	CcSEcCtD
Plerixafor—Urticaria—Alendronate—osteoporosis	0.00162	0.00203	CcSEcCtD
Plerixafor—Ill-defined disorder—Zoledronate—osteoporosis	0.00161	0.00203	CcSEcCtD
Plerixafor—Abdominal pain—Alendronate—osteoporosis	0.00161	0.00202	CcSEcCtD
Plerixafor—Shock—Risedronate—osteoporosis	0.00161	0.00202	CcSEcCtD
Plerixafor—Nervous system disorder—Risedronate—osteoporosis	0.0016	0.00201	CcSEcCtD
Plerixafor—Discomfort—Pamidronate—osteoporosis	0.0016	0.00201	CcSEcCtD
Plerixafor—CXCR4—Disease—LRP6—osteoporosis	0.00159	0.0078	CbGpPWpGaD
Plerixafor—Skin disorder—Risedronate—osteoporosis	0.00159	0.002	CcSEcCtD
Plerixafor—Gastrointestinal pain—Calcitriol—osteoporosis	0.00159	0.002	CcSEcCtD
Plerixafor—Abdominal pain—Raloxifene—osteoporosis	0.00158	0.00199	CcSEcCtD
Plerixafor—Urticaria—Ibandronate—osteoporosis	0.00158	0.00198	CcSEcCtD
Plerixafor—Malaise—Zoledronate—osteoporosis	0.00157	0.00197	CcSEcCtD
Plerixafor—Abdominal pain—Ibandronate—osteoporosis	0.00157	0.00197	CcSEcCtD
Plerixafor—Syncope—Zoledronate—osteoporosis	0.00156	0.00196	CcSEcCtD
Plerixafor—Anaphylactic shock—Pamidronate—osteoporosis	0.00155	0.00195	CcSEcCtD
Plerixafor—Haemoglobin—Estradiol—osteoporosis	0.00155	0.00194	CcSEcCtD
Plerixafor—Urticaria—Calcitriol—osteoporosis	0.00154	0.00194	CcSEcCtD
Plerixafor—Haemorrhage—Estradiol—osteoporosis	0.00154	0.00193	CcSEcCtD
Plerixafor—Abdominal pain—Calcitriol—osteoporosis	0.00154	0.00193	CcSEcCtD
Plerixafor—Shock—Pamidronate—osteoporosis	0.00153	0.00192	CcSEcCtD
Plerixafor—Loss of consciousness—Zoledronate—osteoporosis	0.00153	0.00192	CcSEcCtD
Plerixafor—CXCR4—Disease—LTF—osteoporosis	0.00153	0.0075	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RPL24—osteoporosis	0.00153	0.0075	CbGpPWpGaD
Plerixafor—Hypersensitivity—Estropipate—osteoporosis	0.00152	0.00192	CcSEcCtD
Plerixafor—Nervous system disorder—Pamidronate—osteoporosis	0.00152	0.00192	CcSEcCtD
Plerixafor—Vomiting—Etidronic acid—osteoporosis	0.00152	0.00191	CcSEcCtD
Plerixafor—Connective tissue disorder—Estradiol—osteoporosis	0.00151	0.0019	CcSEcCtD
Plerixafor—Rash—Etidronic acid—osteoporosis	0.00151	0.00189	CcSEcCtD
Plerixafor—Dermatitis—Etidronic acid—osteoporosis	0.00151	0.00189	CcSEcCtD
Plerixafor—Hyperhidrosis—Pamidronate—osteoporosis	0.0015	0.00189	CcSEcCtD
Plerixafor—Syncope—Conjugated Estrogens—osteoporosis	0.0015	0.00189	CcSEcCtD
Plerixafor—Hypersensitivity—Alendronate—osteoporosis	0.0015	0.00189	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PTH1R—osteoporosis	0.0015	0.00737	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CALCR—osteoporosis	0.0015	0.00737	CbGpPWpGaD
Plerixafor—Headache—Etidronic acid—osteoporosis	0.0015	0.00188	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00149	0.00187	CcSEcCtD
Plerixafor—Asthenia—Estropipate—osteoporosis	0.00149	0.00187	CcSEcCtD
Plerixafor—Arthralgia—Zoledronate—osteoporosis	0.00148	0.00186	CcSEcCtD
Plerixafor—Insomnia—Risedronate—osteoporosis	0.00148	0.00186	CcSEcCtD
Plerixafor—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00147	0.00185	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00147	0.00185	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—PTH—osteoporosis	0.00147	0.00722	CbGpPWpGaD
Plerixafor—Paraesthesia—Risedronate—osteoporosis	0.00147	0.00184	CcSEcCtD
Plerixafor—Pruritus—Estropipate—osteoporosis	0.00146	0.00184	CcSEcCtD
Plerixafor—Discomfort—Zoledronate—osteoporosis	0.00146	0.00184	CcSEcCtD
Plerixafor—Asthenia—Alendronate—osteoporosis	0.00146	0.00184	CcSEcCtD
Plerixafor—Hypersensitivity—Ibandronate—osteoporosis	0.00146	0.00184	CcSEcCtD
Plerixafor—Dyspnoea—Risedronate—osteoporosis	0.00146	0.00183	CcSEcCtD
Plerixafor—Dry mouth—Zoledronate—osteoporosis	0.00145	0.00182	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00145	0.00182	CcSEcCtD
Plerixafor—Fatigue—Ethinyl Estradiol—osteoporosis	0.00145	0.00182	CcSEcCtD
Plerixafor—Pruritus—Alendronate—osteoporosis	0.00144	0.00181	CcSEcCtD
Plerixafor—Dyspepsia—Risedronate—osteoporosis	0.00144	0.00181	CcSEcCtD
Plerixafor—Constipation—Ethinyl Estradiol—osteoporosis	0.00143	0.0018	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CNR2—osteoporosis	0.00143	0.00703	CbGpPWpGaD
Plerixafor—Hypersensitivity—Calcitriol—osteoporosis	0.00143	0.0018	CcSEcCtD
Plerixafor—Arthralgia—Conjugated Estrogens—osteoporosis	0.00143	0.00179	CcSEcCtD
Plerixafor—Asthenia—Ibandronate—osteoporosis	0.00142	0.00179	CcSEcCtD
Plerixafor—Nausea—Etidronic acid—osteoporosis	0.00142	0.00178	CcSEcCtD
Plerixafor—Anaphylactic shock—Zoledronate—osteoporosis	0.00142	0.00178	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00142	0.00178	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00142	0.00178	CcSEcCtD
Plerixafor—Diarrhoea—Estropipate—osteoporosis	0.00142	0.00178	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Risedronate—osteoporosis	0.00141	0.00177	CcSEcCtD
Plerixafor—Fatigue—Risedronate—osteoporosis	0.00141	0.00177	CcSEcCtD
Plerixafor—Insomnia—Pamidronate—osteoporosis	0.00141	0.00177	CcSEcCtD
Plerixafor—Pruritus—Ibandronate—osteoporosis	0.0014	0.00176	CcSEcCtD
Plerixafor—Constipation—Risedronate—osteoporosis	0.0014	0.00176	CcSEcCtD
Plerixafor—Pain—Risedronate—osteoporosis	0.0014	0.00176	CcSEcCtD
Plerixafor—Shock—Zoledronate—osteoporosis	0.0014	0.00176	CcSEcCtD
Plerixafor—Paraesthesia—Pamidronate—osteoporosis	0.0014	0.00175	CcSEcCtD
Plerixafor—Diarrhoea—Alendronate—osteoporosis	0.00139	0.00175	CcSEcCtD
Plerixafor—Asthenia—Calcitriol—osteoporosis	0.00139	0.00175	CcSEcCtD
Plerixafor—Nervous system disorder—Zoledronate—osteoporosis	0.00139	0.00175	CcSEcCtD
Plerixafor—Immune system disorder—Estradiol—osteoporosis	0.00139	0.00175	CcSEcCtD
Plerixafor—Dyspnoea—Pamidronate—osteoporosis	0.00139	0.00174	CcSEcCtD
Plerixafor—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00138	0.00174	CcSEcCtD
Plerixafor—Skin disorder—Zoledronate—osteoporosis	0.00138	0.00173	CcSEcCtD
Plerixafor—Pruritus—Calcitriol—osteoporosis	0.00137	0.00173	CcSEcCtD
Plerixafor—Hyperhidrosis—Zoledronate—osteoporosis	0.00137	0.00172	CcSEcCtD
Plerixafor—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00137	0.00172	CcSEcCtD
Plerixafor—Diarrhoea—Raloxifene—osteoporosis	0.00137	0.00172	CcSEcCtD
Plerixafor—Dyspepsia—Pamidronate—osteoporosis	0.00137	0.00172	CcSEcCtD
Plerixafor—Dizziness—Estropipate—osteoporosis	0.00137	0.00172	CcSEcCtD
Plerixafor—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00137	0.00172	CcSEcCtD
Plerixafor—Diarrhoea—Ibandronate—osteoporosis	0.00136	0.00171	CcSEcCtD
Plerixafor—Mental disorder—Estradiol—osteoporosis	0.00135	0.0017	CcSEcCtD
Plerixafor—Dizziness—Alendronate—osteoporosis	0.00135	0.00169	CcSEcCtD
Plerixafor—Shock—Conjugated Estrogens—osteoporosis	0.00135	0.00169	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00134	0.00169	CcSEcCtD
Plerixafor—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00134	0.00168	CcSEcCtD
Plerixafor—Erythema—Estradiol—osteoporosis	0.00134	0.00168	CcSEcCtD
Plerixafor—Fatigue—Pamidronate—osteoporosis	0.00134	0.00168	CcSEcCtD
Plerixafor—Gastrointestinal pain—Risedronate—osteoporosis	0.00134	0.00168	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—PTH—osteoporosis	0.00134	0.00655	CbGpPWpGaD
Plerixafor—Urticaria—Ethinyl Estradiol—osteoporosis	0.00133	0.00167	CcSEcCtD
Plerixafor—Constipation—Pamidronate—osteoporosis	0.00133	0.00167	CcSEcCtD
Plerixafor—Pain—Pamidronate—osteoporosis	0.00133	0.00167	CcSEcCtD
Plerixafor—Diarrhoea—Calcitriol—osteoporosis	0.00133	0.00167	CcSEcCtD
Plerixafor—Skin disorder—Conjugated Estrogens—osteoporosis	0.00133	0.00167	CcSEcCtD
Plerixafor—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00133	0.00167	CcSEcCtD
Plerixafor—Dizziness—Raloxifene—osteoporosis	0.00133	0.00167	CcSEcCtD
Plerixafor—CXCR4—Disease—ACP5—osteoporosis	0.00132	0.0065	CbGpPWpGaD
Plerixafor—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00132	0.00166	CcSEcCtD
Plerixafor—Flatulence—Estradiol—osteoporosis	0.00132	0.00166	CcSEcCtD
Plerixafor—Vomiting—Estropipate—osteoporosis	0.00132	0.00165	CcSEcCtD
Plerixafor—Dizziness—Ibandronate—osteoporosis	0.00131	0.00165	CcSEcCtD
Plerixafor—Rash—Estropipate—osteoporosis	0.00131	0.00164	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.0013	0.0064	CbGpPWpGaD
Plerixafor—Dermatitis—Estropipate—osteoporosis	0.0013	0.00164	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CNR2—osteoporosis	0.0013	0.00639	CbGpPWpGaD
Plerixafor—Urticaria—Risedronate—osteoporosis	0.0013	0.00163	CcSEcCtD
Plerixafor—Headache—Estropipate—osteoporosis	0.0013	0.00163	CcSEcCtD
Plerixafor—Vomiting—Alendronate—osteoporosis	0.0013	0.00163	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00129	0.00163	CcSEcCtD
Plerixafor—Abdominal pain—Risedronate—osteoporosis	0.00129	0.00162	CcSEcCtD
Plerixafor—Rash—Alendronate—osteoporosis	0.00129	0.00161	CcSEcCtD
Plerixafor—Insomnia—Zoledronate—osteoporosis	0.00128	0.00161	CcSEcCtD
Plerixafor—Dermatitis—Alendronate—osteoporosis	0.00128	0.00161	CcSEcCtD
Plerixafor—Feeling abnormal—Pamidronate—osteoporosis	0.00128	0.00161	CcSEcCtD
Plerixafor—Headache—Alendronate—osteoporosis	0.00128	0.0016	CcSEcCtD
Plerixafor—Paraesthesia—Zoledronate—osteoporosis	0.00128	0.0016	CcSEcCtD
Plerixafor—Vomiting—Raloxifene—osteoporosis	0.00127	0.0016	CcSEcCtD
Plerixafor—Gastrointestinal pain—Pamidronate—osteoporosis	0.00127	0.0016	CcSEcCtD
Plerixafor—Dyspnoea—Zoledronate—osteoporosis	0.00127	0.00159	CcSEcCtD
Plerixafor—Rash—Raloxifene—osteoporosis	0.00126	0.00159	CcSEcCtD
Plerixafor—Dermatitis—Raloxifene—osteoporosis	0.00126	0.00159	CcSEcCtD
Plerixafor—Vomiting—Ibandronate—osteoporosis	0.00126	0.00158	CcSEcCtD
Plerixafor—Headache—Raloxifene—osteoporosis	0.00126	0.00158	CcSEcCtD
Plerixafor—Rash—Ibandronate—osteoporosis	0.00125	0.00157	CcSEcCtD
Plerixafor—Dermatitis—Ibandronate—osteoporosis	0.00125	0.00157	CcSEcCtD
Plerixafor—Dyspepsia—Zoledronate—osteoporosis	0.00125	0.00157	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00125	0.00156	CcSEcCtD
Plerixafor—Ill-defined disorder—Estradiol—osteoporosis	0.00124	0.00156	CcSEcCtD
Plerixafor—Headache—Ibandronate—osteoporosis	0.00124	0.00156	CcSEcCtD
Plerixafor—Insomnia—Conjugated Estrogens—osteoporosis	0.00124	0.00155	CcSEcCtD
Plerixafor—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00124	0.00155	CcSEcCtD
Plerixafor—Vomiting—Calcitriol—osteoporosis	0.00124	0.00155	CcSEcCtD
Plerixafor—CXCR4—Disease—TPI1—osteoporosis	0.00123	0.00604	CbGpPWpGaD
Plerixafor—Nausea—Estropipate—osteoporosis	0.00123	0.00154	CcSEcCtD
Plerixafor—Abdominal pain—Pamidronate—osteoporosis	0.00123	0.00154	CcSEcCtD
Plerixafor—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00123	0.00154	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00123	0.00154	CcSEcCtD
Plerixafor—Rash—Calcitriol—osteoporosis	0.00123	0.00154	CcSEcCtD
Plerixafor—Fatigue—Zoledronate—osteoporosis	0.00122	0.00154	CcSEcCtD
Plerixafor—Dermatitis—Calcitriol—osteoporosis	0.00122	0.00154	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—WNT1—osteoporosis	0.00122	0.006	CbGpPWpGaD
Plerixafor—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00122	0.00153	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—PTHLH—osteoporosis	0.00122	0.00598	CbGpPWpGaD
Plerixafor—Headache—Calcitriol—osteoporosis	0.00122	0.00153	CcSEcCtD
Plerixafor—Pain—Zoledronate—osteoporosis	0.00121	0.00153	CcSEcCtD
Plerixafor—Constipation—Zoledronate—osteoporosis	0.00121	0.00153	CcSEcCtD
Plerixafor—Nausea—Alendronate—osteoporosis	0.00121	0.00152	CcSEcCtD
Plerixafor—Malaise—Estradiol—osteoporosis	0.00121	0.00152	CcSEcCtD
Plerixafor—Hypersensitivity—Risedronate—osteoporosis	0.00121	0.00151	CcSEcCtD
Plerixafor—Dyspepsia—Conjugated Estrogens—osteoporosis	0.0012	0.00151	CcSEcCtD
Plerixafor—Asthenia—Ethinyl Estradiol—osteoporosis	0.0012	0.00151	CcSEcCtD
Plerixafor—Syncope—Estradiol—osteoporosis	0.0012	0.00151	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—MGLL—osteoporosis	0.00119	0.00585	CbGpPWpGaD
Plerixafor—Nausea—Raloxifene—osteoporosis	0.00119	0.0015	CcSEcCtD
Plerixafor—Pruritus—Ethinyl Estradiol—osteoporosis	0.00119	0.00149	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00118	0.00148	CcSEcCtD
Plerixafor—Fatigue—Conjugated Estrogens—osteoporosis	0.00118	0.00148	CcSEcCtD
Plerixafor—Nausea—Ibandronate—osteoporosis	0.00118	0.00148	CcSEcCtD
Plerixafor—Loss of consciousness—Estradiol—osteoporosis	0.00118	0.00148	CcSEcCtD
Plerixafor—Asthenia—Risedronate—osteoporosis	0.00117	0.00147	CcSEcCtD
Plerixafor—Feeling abnormal—Zoledronate—osteoporosis	0.00117	0.00147	CcSEcCtD
Plerixafor—Pain—Conjugated Estrogens—osteoporosis	0.00117	0.00147	CcSEcCtD
Plerixafor—Constipation—Conjugated Estrogens—osteoporosis	0.00117	0.00147	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—LRP5—osteoporosis	0.00116	0.00571	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Zoledronate—osteoporosis	0.00116	0.00146	CcSEcCtD
Plerixafor—CXCR4—Disease—P4HB—osteoporosis	0.00116	0.00568	CbGpPWpGaD
Plerixafor—Pruritus—Risedronate—osteoporosis	0.00116	0.00145	CcSEcCtD
Plerixafor—Nausea—Calcitriol—osteoporosis	0.00115	0.00145	CcSEcCtD
Plerixafor—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00115	0.00144	CcSEcCtD
Plerixafor—Hypersensitivity—Pamidronate—osteoporosis	0.00115	0.00144	CcSEcCtD
Plerixafor—Arthralgia—Estradiol—osteoporosis	0.00114	0.00143	CcSEcCtD
Plerixafor—CXCR4—Disease—GAPDH—osteoporosis	0.00114	0.00558	CbGpPWpGaD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00113	0.00142	CcSEcCtD
Plerixafor—Urticaria—Zoledronate—osteoporosis	0.00113	0.00142	CcSEcCtD
Plerixafor—Discomfort—Estradiol—osteoporosis	0.00113	0.00142	CcSEcCtD
Plerixafor—Abdominal pain—Zoledronate—osteoporosis	0.00112	0.00141	CcSEcCtD
Plerixafor—Diarrhoea—Risedronate—osteoporosis	0.00112	0.00141	CcSEcCtD
Plerixafor—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00112	0.0014	CcSEcCtD
Plerixafor—Dry mouth—Estradiol—osteoporosis	0.00112	0.0014	CcSEcCtD
Plerixafor—Asthenia—Pamidronate—osteoporosis	0.00112	0.0014	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—LRP6—osteoporosis	0.00111	0.00547	CbGpPWpGaD
Plerixafor—Dizziness—Ethinyl Estradiol—osteoporosis	0.00111	0.00139	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—PTHLH—osteoporosis	0.00111	0.00543	CbGpPWpGaD
Plerixafor—Pruritus—Pamidronate—osteoporosis	0.0011	0.00138	CcSEcCtD
Plerixafor—Anaphylactic shock—Estradiol—osteoporosis	0.00109	0.00137	CcSEcCtD
Plerixafor—Urticaria—Conjugated Estrogens—osteoporosis	0.00109	0.00136	CcSEcCtD
Plerixafor—Dizziness—Risedronate—osteoporosis	0.00108	0.00136	CcSEcCtD
Plerixafor—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00108	0.00136	CcSEcCtD
Plerixafor—CXCR4—Disease—NFATC1—osteoporosis	0.00108	0.0053	CbGpPWpGaD
Plerixafor—Shock—Estradiol—osteoporosis	0.00108	0.00135	CcSEcCtD
Plerixafor—Nervous system disorder—Estradiol—osteoporosis	0.00107	0.00135	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CALCA—osteoporosis	0.00107	0.00526	CbGpPWpGaD
Plerixafor—CXCR4—Disease—DKK1—osteoporosis	0.00107	0.00526	CbGpPWpGaD
Plerixafor—Vomiting—Ethinyl Estradiol—osteoporosis	0.00107	0.00134	CcSEcCtD
Plerixafor—Diarrhoea—Pamidronate—osteoporosis	0.00106	0.00134	CcSEcCtD
Plerixafor—Skin disorder—Estradiol—osteoporosis	0.00106	0.00134	CcSEcCtD
Plerixafor—Hyperhidrosis—Estradiol—osteoporosis	0.00106	0.00133	CcSEcCtD
Plerixafor—Rash—Ethinyl Estradiol—osteoporosis	0.00106	0.00133	CcSEcCtD
Plerixafor—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00106	0.00133	CcSEcCtD
Plerixafor—Headache—Ethinyl Estradiol—osteoporosis	0.00105	0.00132	CcSEcCtD
Plerixafor—Hypersensitivity—Zoledronate—osteoporosis	0.00105	0.00131	CcSEcCtD
Plerixafor—Vomiting—Risedronate—osteoporosis	0.00104	0.00131	CcSEcCtD
Plerixafor—CXCR4—Disease—WNT1—osteoporosis	0.00103	0.00506	CbGpPWpGaD
Plerixafor—Rash—Risedronate—osteoporosis	0.00103	0.0013	CcSEcCtD
Plerixafor—Dermatitis—Risedronate—osteoporosis	0.00103	0.00129	CcSEcCtD
Plerixafor—Dizziness—Pamidronate—osteoporosis	0.00103	0.00129	CcSEcCtD
Plerixafor—Headache—Risedronate—osteoporosis	0.00102	0.00129	CcSEcCtD
Plerixafor—Asthenia—Zoledronate—osteoporosis	0.00102	0.00128	CcSEcCtD
Plerixafor—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00101	0.00127	CcSEcCtD
Plerixafor—Pruritus—Zoledronate—osteoporosis	0.001	0.00126	CcSEcCtD
Plerixafor—CXCR4—Disease—FGA—osteoporosis	0.001	0.00493	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000997	0.00125	CcSEcCtD
Plerixafor—Nausea—Ethinyl Estradiol—osteoporosis	0.000997	0.00125	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—POMC—osteoporosis	0.000993	0.00487	CbGpPWpGaD
Plerixafor—Insomnia—Estradiol—osteoporosis	0.00099	0.00124	CcSEcCtD
Plerixafor—Vomiting—Pamidronate—osteoporosis	0.000989	0.00124	CcSEcCtD
Plerixafor—Paraesthesia—Estradiol—osteoporosis	0.000983	0.00123	CcSEcCtD
Plerixafor—Asthenia—Conjugated Estrogens—osteoporosis	0.000981	0.00123	CcSEcCtD
Plerixafor—Rash—Pamidronate—osteoporosis	0.00098	0.00123	CcSEcCtD
Plerixafor—Dermatitis—Pamidronate—osteoporosis	0.00098	0.00123	CcSEcCtD
Plerixafor—Dyspnoea—Estradiol—osteoporosis	0.000976	0.00123	CcSEcCtD
Plerixafor—Headache—Pamidronate—osteoporosis	0.000974	0.00122	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CALCA—osteoporosis	0.000974	0.00478	CbGpPWpGaD
Plerixafor—Diarrhoea—Zoledronate—osteoporosis	0.000972	0.00122	CcSEcCtD
Plerixafor—Nausea—Risedronate—osteoporosis	0.000972	0.00122	CcSEcCtD
Plerixafor—Pruritus—Conjugated Estrogens—osteoporosis	0.000968	0.00122	CcSEcCtD
Plerixafor—Dyspepsia—Estradiol—osteoporosis	0.000964	0.00121	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Estradiol—osteoporosis	0.000945	0.00119	CcSEcCtD
Plerixafor—Fatigue—Estradiol—osteoporosis	0.000944	0.00119	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—TLN1—osteoporosis	0.00094	0.00461	CbGpPWpGaD
Plerixafor—Dizziness—Zoledronate—osteoporosis	0.000939	0.00118	CcSEcCtD
Plerixafor—Pain—Estradiol—osteoporosis	0.000936	0.00118	CcSEcCtD
Plerixafor—Constipation—Estradiol—osteoporosis	0.000936	0.00118	CcSEcCtD
Plerixafor—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000936	0.00118	CcSEcCtD
Plerixafor—Nausea—Pamidronate—osteoporosis	0.000924	0.00116	CcSEcCtD
Plerixafor—Dizziness—Conjugated Estrogens—osteoporosis	0.000904	0.00114	CcSEcCtD
Plerixafor—Vomiting—Zoledronate—osteoporosis	0.000903	0.00113	CcSEcCtD
Plerixafor—Feeling abnormal—Estradiol—osteoporosis	0.000902	0.00113	CcSEcCtD
Plerixafor—Rash—Zoledronate—osteoporosis	0.000896	0.00112	CcSEcCtD
Plerixafor—Gastrointestinal pain—Estradiol—osteoporosis	0.000895	0.00112	CcSEcCtD
Plerixafor—CXCR4—Disease—ENO1—osteoporosis	0.000895	0.00439	CbGpPWpGaD
Plerixafor—Dermatitis—Zoledronate—osteoporosis	0.000895	0.00112	CcSEcCtD
Plerixafor—Headache—Zoledronate—osteoporosis	0.00089	0.00112	CcSEcCtD
Plerixafor—CXCR4—Disease—PSMA2—osteoporosis	0.000882	0.00433	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PSMA5—osteoporosis	0.000882	0.00433	CbGpPWpGaD
Plerixafor—Vomiting—Conjugated Estrogens—osteoporosis	0.00087	0.00109	CcSEcCtD
Plerixafor—Urticaria—Estradiol—osteoporosis	0.00087	0.00109	CcSEcCtD
Plerixafor—Abdominal pain—Estradiol—osteoporosis	0.000865	0.00109	CcSEcCtD
Plerixafor—Rash—Conjugated Estrogens—osteoporosis	0.000862	0.00108	CcSEcCtD
Plerixafor—Dermatitis—Conjugated Estrogens—osteoporosis	0.000862	0.00108	CcSEcCtD
Plerixafor—Headache—Conjugated Estrogens—osteoporosis	0.000857	0.00108	CcSEcCtD
Plerixafor—Nausea—Zoledronate—osteoporosis	0.000844	0.00106	CcSEcCtD
Plerixafor—CXCR4—Disease—CALCA—osteoporosis	0.000822	0.00403	CbGpPWpGaD
Plerixafor—Nausea—Conjugated Estrogens—osteoporosis	0.000812	0.00102	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—P4HB—osteoporosis	0.000811	0.00398	CbGpPWpGaD
Plerixafor—Hypersensitivity—Estradiol—osteoporosis	0.000806	0.00101	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PTH—osteoporosis	0.000789	0.00387	CbGpPWpGaD
Plerixafor—Asthenia—Estradiol—osteoporosis	0.000785	0.000986	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—RAP1A—osteoporosis	0.000775	0.0038	CbGpPWpGaD
Plerixafor—Pruritus—Estradiol—osteoporosis	0.000774	0.000973	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CNR2—osteoporosis	0.000769	0.00377	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADCY5—osteoporosis	0.000763	0.00374	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NFATC1—osteoporosis	0.000756	0.00371	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DKK1—osteoporosis	0.00075	0.00368	CbGpPWpGaD
Plerixafor—Diarrhoea—Estradiol—osteoporosis	0.000749	0.000941	CcSEcCtD
Plerixafor—CXCR4—Disease—KL—osteoporosis	0.000746	0.00366	CbGpPWpGaD
Plerixafor—Dizziness—Estradiol—osteoporosis	0.000724	0.000909	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—WNT1—osteoporosis	0.000723	0.00355	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGA—osteoporosis	0.000703	0.00345	CbGpPWpGaD
Plerixafor—Vomiting—Estradiol—osteoporosis	0.000696	0.000874	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ADCY5—osteoporosis	0.000693	0.0034	CbGpPWpGaD
Plerixafor—Rash—Estradiol—osteoporosis	0.00069	0.000867	CcSEcCtD
Plerixafor—Dermatitis—Estradiol—osteoporosis	0.00069	0.000866	CcSEcCtD
Plerixafor—Headache—Estradiol—osteoporosis	0.000686	0.000861	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PTHLH—osteoporosis	0.000654	0.00321	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BMP2—osteoporosis	0.000654	0.00321	CbGpPWpGaD
Plerixafor—Nausea—Estradiol—osteoporosis	0.00065	0.000817	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—FGB—osteoporosis	0.00064	0.00314	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PSMA5—osteoporosis	0.000617	0.00303	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PSMA2—osteoporosis	0.000617	0.00303	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ADCY5—osteoporosis	0.000585	0.00287	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CALCA—osteoporosis	0.000575	0.00282	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—osteoporosis	0.000561	0.00275	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTHFR—osteoporosis	0.000538	0.00264	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KL—osteoporosis	0.000523	0.00256	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IRS2—osteoporosis	0.000511	0.00251	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—osteoporosis	0.00051	0.0025	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6R—osteoporosis	0.000497	0.00244	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IRS1—osteoporosis	0.000446	0.00219	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6R—osteoporosis	0.000419	0.00206	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADCY5—osteoporosis	0.000409	0.00201	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SPP1—osteoporosis	0.000396	0.00194	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IRS2—osteoporosis	0.000358	0.00176	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LEP—osteoporosis	0.00035	0.00172	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ESR1—osteoporosis	0.000335	0.00164	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IRS1—osteoporosis	0.000313	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—osteoporosis	0.000301	0.00148	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6R—osteoporosis	0.000294	0.00144	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1—osteoporosis	0.00029	0.00142	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MYC—osteoporosis	0.000249	0.00122	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFB1—osteoporosis	0.000248	0.00122	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—osteoporosis	0.000221	0.00109	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—osteoporosis	0.000187	0.000917	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MYC—osteoporosis	0.000174	0.000854	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFB1—osteoporosis	0.000174	0.000852	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—osteoporosis	0.000131	0.000642	CbGpPWpGaD
